Clinical trial
Immunogenicity and Reactogenicity of a Meningococcal B Outer Membrane Vesicle…
NCT00197795 · Public Health England, Other · Completed
Key facts
| NCT number | NCT00197795 |
|---|---|
| Title | Immunogenicity and Reactogenicity of a Meningococcal B Outer Membrane Vesicle Vaccine Given in a 0,6,12 Month Schedule to Health UK Adults |
| Lead sponsor | Public Health England, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Neisseria Meningitidis |
| Intervention type | Biological |
| Interventions | Meningococcal outer membrane vesicle vaccine "MenBVac" |
| Enrollment | 30 |
| Start date | Jan 1, 2005 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Sep 20, 2005 |
| Last update posted | Aug 24, 2018 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: